馬斯科技大型工程 MTZ 深 滬
已收盤 01-09 16:00:00 美东时间
218.91
-0.120
-0.05%
華盛通- 最 高226.31
- 今 開221.715
- 成交量 81.86万股
- 最 低 218.445
- 昨 收 219.03
- 總市值 172.72亿
- 52周最高 237.76
- 市盈率 靜 106.08
- 換手率 1.04%
- 52周最低 99.70
- 委 比 31.51%
- 總股本 7890.09万
- 歷史最高 237.76
- 量 比 0.54
- 振 幅 3.59%
- 歷史最低 12.435
- 每 手 1
- 風險率 34.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Goldman’s best fundamental ideas with upside to estimates on upcoming earnings season
Goldman Sachs Research has identified its top fundamental opportunities with expected upside from estimates, highlighting stocks where analysts see significant upside to consensus estimates heading in...
01-09 02:47
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
Stifel Maintains Buy on MasTec, Raises Price Target to $267
Stifel analyst Brian Brophy maintains MasTec (NYSE:MTZ) with a Buy and raises the price target from $240 to $267.
2025-12-17 01:26
Here's How Much You Would Have Made Owning MasTec Stock In The Last 15 Years
MasTec (NYSE:MTZ) has outperformed the market over the past 15 years by 6.63% o...
2025-11-15 07:45
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
2025-11-01 01:26
MasTec shares are trading lower after the company reported Q3 financial results and narrowed its FY25 adjusted EPS guidance.
MasTec shares are trading lower after the company reported Q3 financial results...
2025-10-31 04:23
MasTec Narrows FY2025 Adj EPS Guidance from $6.23-$6.44 to $6.40 vs $6.34 Est; Raises FY2025 Sales Guidance from $13.900B-$14.000B to $14.075B vs $13.988B Est
MasTec (NYSE:MTZ) narrows FY2025 Adj EPS guidance from $6.23-$6.44 to $6.40 vs $6.34 analyst estimate. Raises FY2025 sales outlook from $13.900 billion-$14.000 billion to $14.075 billion vs $13.988 billion estimate.
2025-10-31 04:08
